Ann: Phase 1 onCARlytics Trial Doses First Intravenous Patient, page-5

The main game has kicked off. Sit back and enjoy the game. This is the trial that LC referred to when she said BP and Big Investors in the US are all watching closely. Even the first update will be hugely exciting for us investors.

And we are starting with a much higher dose of CF33 than the MAST trial . So it won’t take long to get to OBD. As LC said it’s a dosing trial with only 52 patients across 3 (?) arms. So it must be close to OBD.

Congratulations to IMU and Prof Fong. It’s just over 4 years since we bought CF33 and less since ONCARLYTICS was invented. Do we are still moving at warp speed here!